These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27799034)

  • 1. Multifunctional Superparamagnetic Nanoparticles: From Synthesis to siRNA Delivery.
    Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
    Curr Pharm Des; 2017; 23(16):2400-2409. PubMed ID: 27799034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel polyacrylate-based cationic nanoparticles for survivin siRNA delivery combined with mitoxantrone for treatment of breast cancer.
    Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
    Biologicals; 2016 Nov; 44(6):487-496. PubMed ID: 27712979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of Fe
    Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
    Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induction activity and molecular docking studies of survivin siRNA carried by Fe
    Arami S; Mahdavi M; Rashidi MR; Yekta R; Rahnamay M; Molavi L; Hejazi MS; Samadi N
    J Pharm Biomed Anal; 2017 Aug; 142():145-154. PubMed ID: 28505590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of survivin siRNA with neoadjuvant chemotherapy enhances apoptosis and reverses drug resistance in breast cancer MCF-7 cells.
    Dong H; Yao L; Bi W; Wang F; Song W; Lv Y
    J Cancer Res Ther; 2015; 11(4):717-22. PubMed ID: 26881507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
    Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H
    Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
    Sargazi A; Shiri F; Keikha S; Majd MH
    Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted silencing of Survivin in cancer cells by siRNA loaded chitosan magnetic nanoparticles.
    Unsoy G; Gunduz U
    Expert Rev Anticancer Ther; 2016 Jul; 16(7):789-97. PubMed ID: 27130312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells.
    Liu L; Li H; Zhang M; Lv X
    Int J Clin Exp Pathol; 2015; 8(6):6674-82. PubMed ID: 26261549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Fu H; Zhang Z; He Q
    J Pharm Sci; 2015 Feb; 104(2):476-84. PubMed ID: 25256603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
    Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
    Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.
    Riehle R; Pattni B; Jhaveri A; Kulkarni A; Thakur G; Degterev A; Torchilin V
    Pharm Res; 2016 Jul; 33(7):1587-601. PubMed ID: 26951567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyetherimide-grafted Fe₃O₄@SiO2₂ nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging.
    Li T; Shen X; Chen Y; Zhang C; Yan J; Yang H; Wu C; Zeng H; Liu Y
    Int J Nanomedicine; 2015; 10():4279-91. PubMed ID: 26170664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional nanocarrier based on clay nanotubes for efficient intracellular siRNA delivery and gene silencing.
    Wu H; Shi Y; Huang C; Zhang Y; Wu J; Shen H; Jia N
    J Biomater Appl; 2014 Apr; 28(8):1180-9. PubMed ID: 23985535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle siRNA against BMI-1 with a Polyethylenimine-Laminarin Conjugate for Gene Therapy in Human Breast Cancer.
    Ren X; Liu L; Zhou Y; Zhu Y; Zhang H; Zhang Z; Li H
    Bioconjug Chem; 2016 Jan; 27(1):66-73. PubMed ID: 26629893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.
    Wu C; Gong F; Pang P; Shen M; Zhu K; Cheng D; Liu Z; Shan H
    PLoS One; 2013; 8(6):e66416. PubMed ID: 23922634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of antiapoptotic genes in breast cancer cells by siRNA loaded into hybrid nanoparticles.
    de Mello LJ; Souza GR; Winter E; Silva AH; Pittella F; Creczynski-Pasa TB
    Nanotechnology; 2017 Apr; 28(17):175101. PubMed ID: 28230534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.